Australia markets closed

Eterna Therapeutics Inc. (ERNA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.0201-0.1399 (-6.48%)
At close: 04:00PM EDT
2.0200 -0.00 (-0.00%)
After hours: 05:42PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 10.93M
Enterprise value 45.20M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)160.73
Price/book (mrq)4.90
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.40

Trading information

Stock price history

Beta (5Y monthly) 8.21
52-week change 3-30.10%
S&P500 52-week change 326.27%
52-week high 32.9900
52-week low 30.8400
50-day moving average 32.1182
200-day moving average 31.9046

Share statistics

Avg vol (3-month) 38.41k
Avg vol (10-day) 36.81k
Shares outstanding 55.41M
Implied shares outstanding 65.41M
Float 82.95M
% held by insiders 139.31%
% held by institutions 116.82%
Shares short (30 Apr 2024) 434.2k
Short ratio (30 Apr 2024) 46.32
Short % of float (30 Apr 2024) 40.83%
Short % of shares outstanding (30 Apr 2024) 40.63%
Shares short (prior month 28 Mar 2024) 442.43k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 317 Oct 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-33,911.76%

Management effectiveness

Return on assets (ttm)-36.19%
Return on equity (ttm)-302.20%

Income statement

Revenue (ttm)68k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -20.59M
Net income avi to common (ttm)-21.68M
Diluted EPS (ttm)-4.0800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.58M
Total cash per share (mrq)1.4
Total debt (mrq)41.84M
Total debt/equity (mrq)1,873.85%
Current ratio (mrq)1.46
Book value per share (mrq)0.41

Cash flow statement

Operating cash flow (ttm)-20.41M
Levered free cash flow (ttm)-13.45M